TiE Angels Boston

General Information
Location: 
76 Blanchard Road Burlington, MA 01803
TiE Angels is an angel investment group organized by TiE-Boston.

North Bridge Venture Partners Business Plan Competition - Entries due May 1

General Information
Location: 
Waltham, MA
Business plan competition - up to $50K in seed capital, $25K in-kind development support, up to six mos. incubation space. Applications due by May 1st.

Founder Collective

General Information
Location: 
New York & Cambridge
Founder Collective is a seed-stage venture capital fund, built by a collection of successful entrepreneurs.

First Growth Venture Network

General Information
Location: 
New York City, NY
First Growth Venture Network's mission is to identify high potential entrepreneurs and to surround them with the network they will need to support their growth.
Cost: 
FREE

fbFund

General Information
Location: 
Palo Alto, CA
Provides funding, mentoring, education, office space and opportunity to present to potential investors for web startups

ECS Angels

General Information
Invests in early-stage enterprises that show the potential and promise of high growth and excellent financial return. No Geographic Limitations

Granite State Angels

General Information
Location: 
Vermont
Brings together over 35 successful and experienced entrepreneurs who are active in making early-stage and seed investments in companies located in the northeastern United States

Investor's Circle

General Information
Location: 
San Francisco, CA
Network of over 225 angel investors, professional venture capitalists, foundations, family offices and others who are using private capital to promote the transition to a sustainable economy.

Maine Angels

General Information
Location: 
Maine
Cooperative mechanism for qualified investors to collaboratively locate, investigate and make investments in promising early-stage companies

Mass Medical Angels (MA2)

General Information
Location: 
Boston region
Our goal is to provide money and mentoring to the life science community to achieve superior returns for our group, and more clinical innovation for the community.
Syndicate content